Diffusion Pharmaceuticals Inc. is incorporated in the State of Delaware.
The Company is headquartered in Charlottesville, VA, USA.
The Diffusion business was established in 2001.
Diffusion Pharmaceuticals became a publicly traded biopharmaceutical company following the close of the merger between Diffusion Pharmaceuticals LLC and a subsidiary of the Company’s predecessor, RestorGenex Corp. (OTC: RESX), on January 8, 2016.
Diffusion Pharmaceutical’s CUSIP number is 0001053691.
The transfer agent for our common stock is Computershare. Communications regarding stock transfer requirements, lost stock certificates, changes of address, or other matters related to your shares may be directed to Computershare via the following methods:
E-mail Inquiries: web.queries@computershare.com
Telephone Inquiries: Toll-Free: 800-368-5948 (US, Canada, Puerto Rico); 781-575-4223 (non-US)
Online Inquiries: https://www-us.computershare.com/investor/Contact
Diffusion Pharmaceuticals’ fiscal year end is December 31.